The case, which was filed in 2018 and involved Sterigenics’ Willowbrook, Ill., plant, surpassed the damages sought by Willowbrook resident Sue Kamuda’s lawyers. The judgment, totaling $363 million, orders Sterigenics to pay $220 million, its parent company to pay $100 million and corporate predecessor Griffith Foods to pay $5 million. Ms. Kamuda was also awarded $38 million in compensatory damages.
Ms. Kamuda’s legal team argued that Sterigenics released the gas at levels thousands of times above what the government considers safe, and that after a decade of exposure to it, she developed breast cancer in 2007, the Sun-Times reported. Sterigenics said it plans to challenge this decision.
“We will continue to vigorously defend against allegations about our ethylene oxide operations and emissions,” the company said in a statement.
Sterigenics’ Willowbrook plant permanently closed in 2019 after 34 years of operations, but the company faces hundreds of lawsuits because of its ethylene oxide gas emissions, according to the Sun-Times.
“It was such a relief,” Ms. Kamuda told the Sun-Times. “It’s been a long four years.”
There are 23 other medical sterilization facilities in the U.S. with ethylene oxide emissions higher than the national limit, according to a recent Environmental Protection Agency report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
